Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-13-071645
Filing Date
2013-02-22
Accepted
2013-02-22 16:58:08
Documents
13
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d444100d10k.htm 10-K 1120446
2 EX-21.1 d444100dex211.htm EX-21.1 3767
3 EX-23.1 d444100dex231.htm EX-23.1 1735
4 EX-31.1 d444100dex311.htm EX-31.1 7735
5 EX-31.2 d444100dex312.htm EX-31.2 7538
6 EX-32.1 d444100dex321.htm EX-32.1 4592
13 GRAPHIC g444100tx24.jpg GRAPHIC 57777
  Complete submission text file 0001193125-13-071645.txt   8839285

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT qdel-20121231.xml EX-101.INS 1313577
8 XBRL TAXONOMY EXTENSION SCHEMA qdel-20121231.xsd EX-101.SCH 70507
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qdel-20121231_cal.xml EX-101.CAL 108104
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qdel-20121231_def.xml EX-101.DEF 195537
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE qdel-20121231_lab.xml EX-101.LAB 621887
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qdel-20121231_pre.xml EX-101.PRE 445492
Mailing Address
Business Address 10165 MCKELLAR CT SAN DIEGO CA 92121 8585521100
QUIDEL CORP /DE/ (Filer) CIK: 0000353569 (see all company filings)

EIN.: 942573850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-10961 | Film No.: 13634971
SIC: 2835 In Vitro & In Vivo Diagnostic Substances